Overview

12-week Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome

Status:
Completed
Trial end date:
2007-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the efficacy and safety of ropinirole CR-RLS in the treatment of patients with Restless Legs Syndrome and associated sleep disturbance and period limb movements during sleep.
Phase:
Phase 4
Details
Lead Sponsor:
GlaxoSmithKline
Treatments:
Ropinirole